These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy. Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212 [No Abstract] [Full Text] [Related]
4. The role of HLA matching in renal transplantation. Ting A; Morris PJ Tissue Antigens; 1985 May; 25(5):225-34. PubMed ID: 3895565 [No Abstract] [Full Text] [Related]
5. DR phenotype matching and transfusion in patients treated with cyclosporine. Cicciarelli J; Terasaki PI Transplant Proc; 1988 Dec; 20(6):1082-3. PubMed ID: 3201554 [No Abstract] [Full Text] [Related]
6. Treatment protocols: is there a role for tissue typing in renal transplantation? Ferguson RM Transplant Proc; 1988 Dec; 20(6 Suppl 8):42-5. PubMed ID: 3059621 [No Abstract] [Full Text] [Related]
12. The impact of center variation on the HLA-DR matching effect in kidney graft survival. Thorogood J; van Houwelingen JC; van Rood JJ; Persijn GG Transplantation; 1989 Aug; 48(2):231-8. PubMed ID: 2667206 [TBL] [Abstract][Full Text] [Related]
13. Beneficial influence of matching for D/DR antigens and treatment with cyclosporin-A on kidney graft survival in transfused rhesus monkeys. Borleffs JC; Marquet RL; Neuhaus P Proc Eur Dial Transplant Assoc; 1981; 18():446-53. PubMed ID: 6460246 [TBL] [Abstract][Full Text] [Related]
14. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine. Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632 [No Abstract] [Full Text] [Related]
15. Blood transfusions and HLA compatibility in first cadaveric kidney transplants treated with cyclosporine A. Garcia LF; Arango AM; Henao JE; Arbelaez M Transplant Proc; 1988 Aug; 20(4):715-9. PubMed ID: 3043844 [TBL] [Abstract][Full Text] [Related]
16. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results. Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870 [No Abstract] [Full Text] [Related]
17. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study. Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A effective therapy for fifty-two cadaver kidney recipients. Takagi H; Uchida K; Ohshima S; Fujita T; Kano T; Asano H; Ono Y Jpn J Surg; 1985 Mar; 15(2):160-5. PubMed ID: 3892112 [TBL] [Abstract][Full Text] [Related]